Leveraging Chatbot to Improve PrEP in the Southern United States

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 31 days later Feb 28, 2027 → Mar 31, 2027
See other at-risk trials from Yale University

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 6 more changesShow less
    • Primary completion pushed from Feb 28, 2027 to Mar 31, 2027
    • Start date changed from estimate of Jul 20, 2026 to Jul 13, 2026
    • Eligibility criteria expanded, about 29 words
    • Secondary endpoints revised (6)
    • Site details revised at 4 of 4 sites
    • Publications: details revised at 3 of 3 entries
  2. Primary completion pushed from Jul 1, 2026 to Feb 28, 2027
    • Start date: Mar 28, 2026 to Jul 20, 2026
    • Study completion pushed from Jul 1, 2026 to Jul 1, 2027
    v9
  3. Start date: Oct 28, 2025 to Mar 28, 2026
    • Primary and study completion dates: Feb 1, 2026 to Jul 1, 2026
    v8
  4. Start date: Jun 28, 2025 to Oct 28, 2025
    • Primary and study completion dates: Oct 1, 2025 to Feb 1, 2026
    v7
  5. Start date: Feb 28, 2025 to Jun 28, 2025
    • Primary and study completion dates: Jun 1, 2025 to Oct 1, 2025
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Start date: Sep 10, 2024 to Feb 28, 2025v5
  2. Start date: Jun 2024 to Sep 10, 2024v4
  3. Start date: Mar 2024 to Jun 2024
    • Primary and study completion dates: Mar 1, 2025 to Jun 1, 2025
    v3
  4. Start date: Dec 1, 2023 to Mar 2024
    • Primary completion date: Dec 1, 2024 to Mar 1, 2025
    • Study completion date: Jun 1, 2025 to Mar 1, 2025
    v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Yale University
490 trials monitored
See 31 trials at risk
The purpose of this study is to develop a chatbot intervention to promote PrEP awareness and uptake among Black men who have sex with men (MSM) in the Southern United States.
Trial Details
NCT Number NCT05968755
Lead Sponsor Yale University
Collaborators: Gilead Sciences
Conditions
(from sponsor)		 HIV Prevention, PrEP Awareness, PrEP Uptake
Enrollment 145 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov